GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (FRA:1KA) » Definitions » Marketable Securities

GH Research (FRA:1KA) Marketable Securities : €73.95 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is GH Research Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. GH Research's Marketable Securities for the quarter that ended in Mar. 2024 was €73.95 Mil.

GH Research's annual Marketable Securities stayed the same from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil) but then increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€76.24 Mil).

GH Research Marketable Securities Historical Data

The historical data trend for GH Research's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research Marketable Securities Chart

GH Research Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
- - - - 76.24

GH Research Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.93 63.22 70.12 76.24 73.95

GH Research Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

GH Research  (FRA:1KA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

GH Research Marketable Securities Related Terms

Thank you for viewing the detailed overview of GH Research's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

GH Research (FRA:1KA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (FRA:1KA) » Definitions » Marketable Securities
Comparable Companies
IMNM CDMO BMEA MRNS ORTX ALXO ORIC RNA ITOS URGN OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
GHRS:USA
Address
28 Baggot Street Lower, Dublin, IRL, D02 NX43
Website
https://www.ghres.com
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.

GH Research (FRA:1KA) Headlines

No Headlines